Clinical Trial Update: CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes [NA]

View source ↗

Summary

The CAPO trial evaluating continuous glucose monitoring in gestational diabetes and its impact on pregnancy outcomes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: Yale University | Conditions: Gestational Diabetes, Maternal Complication of Pregnancy | NA | Status: COMPLETED | Results posted: 2025-08-28